½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1363832

¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø, ±â¼úº°, ±â°üº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Perfusion Systems Market Size study & Forecast, by Technology (Normothermic Machine Perfusion, Hypothermic Machine Perfusion) by Organ ( Heart, Lung, Kidney, Liver, Others) and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°ü·ù ½Ã½ºÅÛÀº ÀÇ·á ¹× °úÇÐ ºÐ¾ß¿¡¼­ Á¶Á÷°ú Àå±â¿¡ »ê¼Ò¿Í ¿µ¾çÀÌ Ç³ºÎÇÑ ¾×ü¸¦ Áö¼ÓÀûÀ¸·Î °ø±ÞÇϱâ À§ÇØ »ç¿ëµÇ´Â ÀåÄ¡ ¹× ±â¼úÀÔ´Ï´Ù.

ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ü³»ÀÇ ÀÚ¿¬ÀûÀÎ Ç÷¾× ¼øȯÀ» ¸ð¹æÇϵµ·Ï ¼³°èµÇ¾î ü¿Ü¿¡¼­ Á¶Á÷À» º¸Á¸Çϰųª ¿¬±¸ÇÒ ¼ö ÀÖ´Â ÅëÁ¦µÈ ȯ°æÀ» Á¦°øÇÕ´Ï´Ù. °ü·ù ½Ã½ºÅÛÀº Àå±â À̽Ŀ¡¼­ ÀÌ½Ä Àü Àå±â¸¦ º¸Á¸ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. °ü·ù ½Ã½ºÅÛÀº »ê¼Ò¿Í ¿µ¾çºÐÀ» °ø±ÞÇÏ°í, ³ëÆó¹°À» Á¦°ÅÇÏ°í, ¿Âµµ¿Í ¾Ð·ÂÀ» Á¶ÀýÇÏ¿© Àå±âÀÇ »ýÁ¸ ´É·Â°ú ±â´ÉÀ» À¯ÁöÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. °ü·ù ½Ã½ºÅÛ ½ÃÀåÀº Àå±â ÀÌ½Ä »ç·Ê Áõ°¡, ½ÉÇ÷°ü ¹× È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

½ÉÀå À̽Ä, °£ À̽Ä, ½ÅÀå À̽Ä, Æó À̽İú °°Àº Àå±â À̽Ŀ¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °í±Þ °ü·ù ½Ã½ºÅÛÀÇ Çʿ伺ÀÌ Å©°Ô Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. °ü·ù ½Ã½ºÅÛÀº ±âÁõÀÚÀÇ Àå±â¸¦ ü¿Ü¿¡¼­ º¸Á¸ÇÏ°í Æò°¡ÇÏ¿© ÀÌ½Ä ¼º°ø·üÀ» ³ôÀÌ°í »ç¿ë °¡´ÉÇÑ Àå±â Ç®À» È®ÀåÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. 2022³â 3¿ù ¹Ì±¹ º¸°ÇÀÚ¿ø¼­ºñ½º±¹ÀÌ ¹ßÇ¥ÇÑ Á¤º¸¿¡ µû¸£¸é 2021³â ¹Ì±¹¿¡¼­ ¾à 4¸¸ °ÇÀÇ Àå±â À̽ÄÀÌ ÀÌ·ç¾îÁ³½À´Ï´Ù. ¶ÇÇÑ 2021³â¿¡ ¹Ì±¹¿¡¼­ ÁøÇàµÈ Àå±â À̽ÄÀº »ýü ÀÌ½Ä 9,236°Ç, ½ÅÀå ÀÌ½Ä 2¸¸ 6,670°ÇÀ̾ú½À´Ï´Ù. ¶ÇÇÑ ±¹Á¦½ÅÀåÇÐȸ(ISN)¿Í ±¹Á¦½ÅÀåÀç´Ü¿¬¸Í(IFKF)ÀÌ 2021³â¿¡ ¹ßÇ¥ÇÑ ¼öÄ¡¿¡ µû¸£¸é, ½ÅÀ庴Àº ¼¼°èÀûÀ¸·Î ¾à 8¾ï 5,000¸¸ ¸íÀÌ ¾Î°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¶ÇÇÑ, ¼¼°è Àα¸ 10¸í Áß 1¸íÀÌ ¸¸¼º½ÅÀ庴(CKD)À» ¾Î°í ÀÖÀ¸¸ç, ¼¼°è ¸¸¼º½ÅÀ庴ÀÇ ºÎ´ãÀº Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÏ¿©, ¿À´Â 2040³â¿¡´Â ¸¸¼º½ÅÀ庴ÀÌ ¼¼°è 5À§ »ç¸Á¿øÀÎÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÈ´Ù°í ¹àÇû½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¸¸¼º ½ÅÀå ÁúȯÀÇ ºóµµ¿Í ÇÔ²² ½ÅÀå À̽ÄÀÇ Çʿ伺ÀÌ Áõ°¡ÇÏ¿© ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÀÌ½Ä ±â¼úÀÇ ¹ßÀü°ú Àå±â ±âÁõÀ» ÃËÁøÇϱâ À§ÇÑ Á¤ºÎ ¹× ´Ù¾çÇÑ ´ÜüÀÇ À̴ϼÅƼºê°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇÏ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç°ú ´ëü Ä¡·á¹ýÀÇ °¡¿ë¼ºÀº 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÏ°í ÀÖ½À´Ï´Ù.

¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ÀÇ ¿ìÀ§, ´Ù¾çÇÑ ¸¸¼º Áúȯ ¹× ½ÉÇ÷°ü Áúȯ Áõ°¡, Àå±â ÀÌ½Ä »ç·Ê Áõ°¡, ÀÌ Áö¿ªÀÇ ±â¼ú ¹ßÀüÀ» À§ÇÑ À̴ϼÅƼºê Áõ°¡·Î ÀÎÇØ 2022³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ½ÉÇ÷°ü ¹× È£Èí±â Áúȯ°ú °°Àº Áúº´ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ °¡Àå ºü¸¥ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â Àå±â À̽İú °ü·ÃµÈ Á¤ºÎÀÇ ¿ìÈ£Àû ÀÎ »óȯ Á¤Ã¥°ú ÀÇ·á ÁöÃâ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÏ°í ÀÖ½À´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆľÇÇÏ°í ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀåÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵ˴ϴÙ.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ ¹ßÀü
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó ³âµµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå ¿ªÇÐ

  • °ü·ù ½Ã½ºÅÛ ½ÃÀå ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • ½ÃÀå ±âȸ

Á¦4Àå ¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19ÀÇ ¿µÇ⠺м®
  • Æı«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå : ±â¼úº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå : ±â¼úº°, ½ÇÀû¡¤°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå : ±â¼úº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • °ü·ù ½Ã½ºÅÛ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • »ó¿Â ±â°è°ü·ù
    • Àú¿Â ±â°è°ü·ù

Á¦6Àå ¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå : Àå±âº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå : Àå±âº°, ½ÇÀû¡¤°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå : Àå±âº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • °ü·ù ½Ã½ºÅÛ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ½ÉÀå
    • Æó
    • ½ÅÀå
    • °£
    • ±âŸ

Á¦7Àå ¼¼°èÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå, Áö¿ª ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • °ü·ù ½Ã½ºÅÛ ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • ±â¼úº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • Àå±âº°, ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ °ü·ù ½Ã½ºÅÛ ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Bridge to Life(Europe) Ltd.
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
      • Á¦Ç° °³¿ä
    • Organ Assist B.V.
    • Organ Recovery Systems, Inc
    • OrganOx Limited
    • Paragonix Technologies, Inc.
    • Preservation Solutions Inc
    • TransMedics, Inc.
    • Waters Medical Systems LLC
    • XVIVO Perfusion AB
    • Repligen Corporation

Á¦9Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
LSH 23.11.06

Perfusion systems are devices or techniques used in medical and scientific fields to deliver a continuous flow of oxygenated and nutrient-rich fluid to tissues or organs. These systems are designed to mimic the natural blood circulation in the body and provide a controlled environment for preserving or studying tissues outside of the body. Perfusion systems are utilized in organ transplantation to preserve organs before transplantation. They help to maintain the viability and function of organs by delivering oxygen and nutrients, removing waste products, and controlling temperature and pressure. The Perfusion Systems market is expanding because of factors such as rising cases of organ transplant and increase in the prevalence of cardiovascular and respiratory diseases.

The growing demand for organ transplants, including heart, liver, kidney, and lung transplants, has significantly increased the need for advanced perfusion systems. Perfusion systems play a crucial role in preserving and assessing donor organs outside the body, improving the success rates of transplants and expanding the pool of available organs. According to information released by the Health Resources and Services Administration in March 2022, around 40,000 organ transplants were carried out in the United States in 2021. Also carried out in the United States in 2021 were 9,236 live transplants and 26,670 kidney transplants. Furthermore, according to figures published in 2021 by the International Society of Nephrology (ISN) and International Federation of renal Foundations (IFKF), renal disease afflicted almost 850.0 million individuals globally. The same source also stated that one in ten people globally have chronic kidney disease (CKD). By 2040, it is anticipated that CKD would rank as the fifth most prevalent cause of death globally because of its steadily rising global burden. As a result, the need for kidney transplants is anticipated to rise along with the frequency of chronic renal disease, fueling market expansion. In addition, advancement in transplantation techniques and rising initiatives by government and various organizations to promote organ donations is creating a lucrative opportunity to the market. However, the stringent regulatory requirements and availability of alternative treatment method stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Perfusion Systems Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the dominance of key market players, rising prevelance of various chronic and cardiovascular diseases, rising organ transplant cases, and rising initiatives for technological advancement in the region. Whereas, Asia Pacific region is projected to have fastest growth owing to factors such as rising prevelance of diseases such as cardiovascular and respiratory diseases. In the region, favorable government reimbursement polices related to organ transplantation, and increasing healthcare expenditure is supporting the market growth.

Major market player included in this report are:

  • Bridge to Life (Europe) Ltd.
  • Organ Assist B.V.
  • Organ Recovery Systems, Inc
  • OrganOx Limited
  • Paragonix Technologies, Inc.
  • Preservation Solutions Inc
  • TransMedics, Inc.
  • Waters Medical Systems LLC
  • XVIVO Perfusion AB
  • Repligen Corporation

Recent Developments in the Market:

  • In February 2023, In Europe, LivaNova announced a limited commercial distribution of its Essenz perfusion system. After successfully implementing in The Netherlands and Italy, the company started its debut in a few key locations across Europe. The Essenz system was developed by London-based LivaNova and includes a patient monitor and a cutting-edge heart-lung machine. It was created by the company to give a patient-tailored strategy that enables data-driven decisions during cardiopulmonary bypass treatments.
  • In January 2022, The FDA granted 510(k) approval to XVIVO for their Kidney Assist Transport, a transportable organ perfusion system that provides continuous oxygenated perfusion for up to 24 hours. The device has been shown to enhance preservation when compared to cold storage.

Global Perfusion Systems Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Technology, Organ, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Technology:

  • Normothermic Machine Perfusion
  • Hypothermic Machine Perfusion

By Organ:

  • Heart
  • Lung
  • Kidney
  • Liver
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Perfusion Systems Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Perfusion Systems Market, by Technology, 2020-2030 (USD Billion)
    • 1.2.3. Perfusion Systems Market, by Organ, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Perfusion Systems Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Perfusion Systems Market Dynamics

  • 3.1. Perfusion Systems Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of organ transplant cases
      • 3.1.1.2. Increase in the prevalence of cardiovascular and respiratory diseases.
    • 3.1.2. Market Challenges
      • 3.1.2.1. Stringent regulatory requirements
      • 3.1.2.2. Availability of alternative treatment method
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancement in transplant techniques
      • 3.1.3.2. Rising initiatives by government and various organizations to promote organ donations

Chapter 4. Global Perfusion Systems Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Perfusion Systems Market, by Technology

  • 5.1. Market Snapshot
  • 5.2. Global Perfusion Systems Market by Technology, Performance - Potential Analysis
  • 5.3. Global Perfusion Systems Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
  • 5.4. Perfusion Systems Market, Sub Segment Analysis
    • 5.4.1. Normothermic Machine Perfusion
    • 5.4.2. Hypothermic Machine Perfusion

Chapter 6. Global Perfusion Systems Market, by Organ

  • 6.1. Market Snapshot
  • 6.2. Global Perfusion Systems Market by Organ, Performance - Potential Analysis
  • 6.3. Global Perfusion Systems Market Estimates & Forecasts by Organ 2020-2030 (USD Billion)
  • 6.4. Perfusion Systems Market, Sub Segment Analysis
    • 6.4.1. Heart
    • 6.4.2. Lung
    • 6.4.3. Kidney
    • 6.4.4. Liver
    • 6.4.5. Others

Chapter 7. Global Perfusion Systems Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Perfusion Systems Market, Regional Market Snapshot
  • 7.4. North America Perfusion Systems Market
    • 7.4.1. U.S. Perfusion Systems Market
      • 7.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Organ breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Perfusion Systems Market
  • 7.5. Europe Perfusion Systems Market Snapshot
    • 7.5.1. U.K. Perfusion Systems Market
    • 7.5.2. Germany Perfusion Systems Market
    • 7.5.3. France Perfusion Systems Market
    • 7.5.4. Spain Perfusion Systems Market
    • 7.5.5. Italy Perfusion Systems Market
    • 7.5.6. Rest of Europe Perfusion Systems Market
  • 7.6. Asia-Pacific Perfusion Systems Market Snapshot
    • 7.6.1. China Perfusion Systems Market
    • 7.6.2. India Perfusion Systems Market
    • 7.6.3. Japan Perfusion Systems Market
    • 7.6.4. Australia Perfusion Systems Market
    • 7.6.5. South Korea Perfusion Systems Market
    • 7.6.6. Rest of Asia Pacific Perfusion Systems Market
  • 7.7. Latin America Perfusion Systems Market Snapshot
    • 7.7.1. Brazil Perfusion Systems Market
    • 7.7.2. Mexico Perfusion Systems Market
  • 7.8. Middle East & Africa Perfusion Systems Market
    • 7.8.1. Saudi Arabia Perfusion Systems Market
    • 7.8.2. South Africa Perfusion Systems Market
    • 7.8.3. Rest of Middle East & Africa Perfusion Systems Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Bridge to Life (Europe) Ltd.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Organ Assist B.V.
    • 8.3.3. Organ Recovery Systems, Inc
    • 8.3.4. OrganOx Limited
    • 8.3.5. Paragonix Technologies, Inc.
    • 8.3.6. Preservation Solutions Inc
    • 8.3.7. TransMedics, Inc.
    • 8.3.8. Waters Medical Systems LLC
    • 8.3.9. XVIVO Perfusion AB
    • 8.3.10. Repligen Corporation

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦